http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006068002-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62 |
| filingDate | 2005-11-16^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92827e6b4d77485dc03042e75cb4b205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41522fc80728663fccbe430cfc2fad15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d1deba34b993b60b59fc791c263213 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef24863dafe1f95fa53cd96aef9d0ac7 |
| publicationDate | 2006-03-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2006068002-A1 |
| titleOfInvention | Extended release formulation |
| abstract | This invention relates to a 24 hour extended release dosage formulation and unit dosage form thereof of venlafaxine hydrochloride, an antidepressant, which provides better control of blood plasma levels than conventional tablet formulations which must be administered two or more times a day and further provides a lower incidence of nausea and vomiting than the conventional tablets. More particularly, the invention comprises an extended release formulation of venlafaxine hydrochloride comprising a therapeutically effective amount of venlafaxine hydrochloride in spheroids comprised of venlafaxine hydrochloride, microcrystalline cellulose and, optionally, hydroxypropylmethylcellulose coated with a mixture of ethyl cellulose and hydroxypropylmethylcellulose. |
| priorityDate | 1996-03-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 75 of 75.